Evidence map›Paper›PMID 32054903›Full record

Trial reportScientific reports2020

Lung Surfactant Accelerates Skin Wound Healing: A Translational Study with a Randomized Clinical Phase I Study.

Ursula Mirastschijski, Igor Schwab, Vincent Coger, Ulrich Zier, Carmela Rianna, Wei He, Kathrin Maedler, Sørge Kelm, Arlo Radtke, Gazanfer Belge and 5 more

Open access · goldAbstract readClinical Trial, Phase IRandomized Controlled Trial
In one paragraph

Trial report in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
1.9field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 22 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Genital Wound Repair and Scarring.Medical sciences (Basel, Switzerland) · 2022
    Review
  6. Review
  7. Review
  8. Article
  9. The Inhibitory Effect of CurosurfFrontiers in immunology · 2020
    Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors at 4 institutions in 1 country.

Ursula Mirastschijski *Center for Biomolecular Interactions Bremen, Faculty of Biology and Chemistry, University of Bremen, Bremen, Germany. mirastsc@uni-bremen.de.ORCID http://orcid.org/0000-0003-3964-8851
Igor Schwab *Department of Plastic, Reconstructive and Aesthetic Surgery, Klinikum Bremen-Mitte, Bremen, Germany.
Vincent CogerDepartment of Experimental Plastic Surgery, Kerstin Reimers Laboratory for Regeneration Biology, Hannover Medical School, Hannover, Germany.
Ulrich ZierCenter for Biomolecular Interactions Bremen, Faculty of Biology and Chemistry, University of Bremen, Bremen, Germany.
Carmela RiannaInstitute of Biophysics, University of Bremen, Bremen, Germany.
Wei HeCenter for Biomolecular Interactions Bremen, Faculty of Biology and Chemistry, University of Bremen, Bremen, Germany.
Kathrin MaedlerCenter for Biomolecular Interactions Bremen, Faculty of Biology and Chemistry, University of Bremen, Bremen, Germany.
Sørge KelmCenter for Biomolecular Interactions Bremen, Faculty of Biology and Chemistry, University of Bremen, Bremen, Germany.
Arlo RadtkeFaculty of Biology and Chemistry, University of Bremen, Bremen, Germany.
Gazanfer BelgeFaculty of Biology and Chemistry, University of Bremen, Bremen, Germany.
Patrick LindnerInstitute of Technical Chemistry, Leibniz University Hannover, Hannover, Germany.
Frank StahlInstitute of Technical Chemistry, Leibniz University Hannover, Hannover, Germany.
Martin ScharpenbergUniversity of Bremen, Competence Center for Clinical Trials Bremen, Bremen, Germany.ORCID http://orcid.org/0000-0003-1584-0056
Lukas LasotaUniversity of Bremen, Competence Center for Clinical Trials Bremen, Bremen, Germany.
Jürgen TimmUniversity of Bremen, Competence Center for Clinical Trials Bremen, Bremen, Germany.
University of Bremen · DELeibniz University Hannover · DEKlinikum Bremen-Mitte · DEMedizinische Hochschule Hannover · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Lung surfactants are used for reducing alveolar surface tension in preterm infants to ease breathing. Phospholipid films with surfactant proteins regulate the activity of alveolar macrophages and reduce inflammation. Aberrant skin wound healing is characterized by persistent inflammation. The aim of the study was to investigate if lung surfactant can promote wound healing. Preclinical wound models, e.g. cell scratch assays and full-thickness excisional wounds in mice, and a randomized, phase I clinical trial in healthy human volunteers using a suction blister model were used to study the effect of the commercially available bovine lung surfactant on skin wound repair. Lung surfactant increased migration of keratinocytes in a concentration-dependent manner with no effect on fibroblasts. Significantly reduced expression levels were found for pro-inflammatory and pro-fibrotic genes in murine wounds. Because of these beneficial effects in preclinical experiments, a clinical phase I study was initiated to monitor safety and tolerability of surfactant when applied topically onto human wounds and normal skin. No adverse effects were observed. Subepidermal wounds healed significantly faster with surfactant compared to control. Our study provides lung surfactant as a strong candidate for innovative treatment of chronic skin wounds and as additive for treatment of burn wounds to reduce inflammation and prevent excessive scarring.

Indexed as

AnimalsBlisterCell ProliferationCicatrixFemaleFibroblastsHumansInflammationKeratinocytesMicePulmonary Surfactant-Associated ProteinsSkinSurface-Active AgentsWound HealingPulmonary Surfactant-Associated ProteinsSurface-Active Agents

Identifiers

PMID32054903
PMCPMC7018835
OpenAlexW3005575481

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.